Drug name - Fycompa
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6949571 | EISAI INC | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
Jun, 2022
(3 months ago) | |
| US8772497 | EISAI INC | Method for producing 1, 2-dihydropyridine-2-one compound |
Jul, 2026
(3 years from now) | |
| CN1436172A | EISAI INC | 1, 2-Dihydro-Pyridine Compound And Preparation Method And Use Thereof |
Jun, 2021
(1 year, 3 months ago) | |
| CN1245386C | EISAI INC | 1, 2-Dihydro-Pyridine Compound And Preparation Method And Use Thereof |
Jun, 2021
(1 year, 3 months ago) | |
| CN101914057A | EISAI INC | Crystal Of 1,2-Dihydropyridine Compound |
Jul, 2025
(2 years from now) | |
| CN101544599B | EISAI INC | Crystal Of 1,2-Dihydropyridine Compound |
Jul, 2025
(2 years from now) | |
| CN1942443A | EISAI INC | The Crystal Of 1,2-Dihydropyridine Compound And The Manufacturing Method |
Jul, 2025
(2 years from now) | |
| CN102382047B | EISAI INC | 1, 2-Dihydro-Pyridine Compound Crystal |
Jul, 2025
(2 years from now) | |
| CN101914057B | EISAI INC | 1, 2-Dihydro-Pyridine Compound Crystal |
Jul, 2025
(2 years from now) | |
| CN101544599A | EISAI INC | Crystal Of 1,2-Dihyropyridin Compound |
Jul, 2025
(2 years from now) | |
| CN1942443B | EISAI INC | 1, 2-Dihydro-Pyridine Compound Crystal And Preparation Method Thereof |
Jul, 2025
(2 years from now) | |
| CN102382047A | EISAI INC | Crystal Of 1,2-Dihydropyridine Compound |
Jul, 2025
(2 years from now) | |
| IN200600561P3 | EISAI INC | 1-2 Dihydropyridine Compounds, Process For Preparation Of The Same And Use Threof |
Jun, 2021
(1 year, 3 months ago) | |
| IN202869B | EISAI INC | Production Process Of 1,2-Dihydropyridine Compounds |
Jun, 2021
(1 year, 3 months ago) | |
| IN291766B | EISAI INC | 1-2 Dihydropyridine Compounds, Process For Preparation Of The Same And Use Thereof |
Jun, 2021
(1 year, 3 months ago) | |
| EP1764361B1 | EISAI INC | Crystal Of 1,2-Dihydropyridine Compound And Method For Producing Same |
Jul, 2025
(2 years from now) | |
| EP1772450A4 | EISAI INC | Method For Producing 1,2-Dihydropyridine-2-One Compound |
Jul, 2025
(2 years from now) | |
| EP1764361A1 | EISAI INC | Crystal Of 1,2-Dihydropyridine Compound And Method For Producing Same |
Jul, 2025
(2 years from now) | |
| EP1764361A4 | EISAI INC | Crystal Of 1,2-Dihydropyridine Compound And Method For Producing Same |
Jul, 2025
(2 years from now) | |
| EP1772450B1 | EISAI INC | Method For Producing 1,2-Dihydropyridine-2-One Compound |
Jul, 2025
(2 years from now) | |
| EP1772450A1 | EISAI INC | Method For Producing 1,2-Dihydropyridine-2-One Compound |
Jul, 2025
(2 years from now) | |
| EP1300396A1 | EISAI INC | 1,2-Dihydropyridine Compounds, Process For Preparation Of The Same And Use Thereof |
Jun, 2026
(3 years from now) | |
| EP1300396B1 | EISAI INC | 1,2-Dihydropyridine Compounds, Process For Preparation Of The Same And Use Thereof |
Jun, 2026
(3 years from now) | |
| EP1300396A4 | EISAI INC | 1,2-Dihydropyridine Compounds, Process For Preparation Of The Same And Use Thereof |
Jun, 2026
(3 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.5MG/ML | SUSPENSION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.